Progressive supranuclear palsy : diagnosis, pathology, and therapy /

This monograph summarizes recent developments in clinical and basic research in progressive supranuclear palsy (PSP). This disorder is the second most common cause of parkinsonism seen in practice. Only recently we have been able to diagnose it regularly in living patients. There is an outporing of...

Full description

Bibliographic Details
Corporate Author:	SpringerLink (Online service)
Other Authors:	Tolosa, Eduardo (Editor), Duvoisin, Roger C., 1927- (Editor), Cruz-Sánchez, F. F. (Felix F.) (Editor)
Format:	eBook
Language:	English
Published:	Wien ; New York : Springer-Verlag, 1994.
Subjects:	Progressive supranuclear palsy. Supranuclear Palsy, Progressive > diagnosis. Electronic books.
Online Access:	Connect to the full text of this electronic book

Table of Contents:

Clinical aspects
Historical notes
Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)
Eyelid motor abnormalities in progressive supranuclear palsy
he auditory startle response in progressive supranuclear palsy
Differential diagnosis of PSP
Cognitive disturbances in progressive supranuclear palsy
Progressive supranuclear palsy and corticobasal ganglionic degeneration: differentiation by clinical features and neuroimaging techniques
Neuroimage analysis, cerebral blood flow, and metabolism
Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders
Clinical progressive supranuclear palsy: differential diagnosis by IBZM-SPECT and MRI
PET studies in progressive supranuclear palsy
Morphological aspects
The neuropathology of progressive supranuclear palsy
Neurofibrillary pathology in progressive supranuclear palsy (PSP)
Antigenic determinant properties of neurofibrillary tangles. Relevance to progressive supranuclear palsy
Cortical tangles in progressive supranuclear palsy
Vascular progressive supranuclear palsy
Biochemical aspects
Cholinergic and peptidergic systems in PSP
Brain monoamines in progressive supranuclear palsycomparison with idiopathic Parkinsons disease
Alterations of neurotransmitter receptors and neurotransmitter transporters in progressive supranuclear palsy
Changes in aminergic receptors in a PSP postmortem brain: correlation with pathological findings
Epidemiology and treatment
The epidemiology of PSP
Cholinergic approaches to the treatment of progressive supranuclear palsy
Therapy for progressive supranuclear palsy: past and future.